Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone ResistancePatrick N. A. Harris, David L. Paterson, Paul Anantharajah Tambyah et al.|JAMA|2018Cited by 761
Detection of Tuberculosis in HIV-Infected and -Uninfected African Adults Using Whole Blood RNA Expression Signatures: A Case-Control StudyMyrsini Kaforou, Michael Levin, Amelia C. Crampin et al.|PLoS Medicine|2013Cited by 388
Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO StudyAndrew Henderson, Bassam Alalwan, David L. Paterson et al.|Clinical Infectious Diseases|2020Cited by 155
The WHO essential medicines list AWaRe book: from a list to a quality improvement systemBenedikt Huttner, Veronica Zanichelli, Loice Achieng Ombajo et al.|Clinical Microbiology and Infection|2022Cited by 125
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical PathwaySujith J Chandy, Massimo Sartelli, Yoram Kluger et al.|Surgical Infections|2017Cited by 58